On April 9th, Jincheng Pharm (300233.SZ) underwent an investigation by institutions. The company's key executive team personally participated in the reception and provided comprehensive responses to the relevant questions.
Jincheng Pharm stated that the company currently only produces raw materials for e-cigarettes and does not directly manufacture finished e-cigarette products. The company has successfully industrialized the synthesis and extraction of nicotine, and is currently expanding its market and monitoring developments in the new tobacco industry. Depending on market conditions, they will decide whether to enter this new sector. Currently, related products are still in the development process.
Inquiries from institutions ask: what is the usage rate and market penetration of e-cigarettes? In 2019, 50.4% of American smokers had already used e-cigarettes. In contrast, only 1.2% of Chinese smokers had used them. This indicates that there is a huge potential for development in the Chinese e-cigarette market.
In response, Jincheng Pharm stated that they will continue to improve the quality of nicotine used in e-cigarettes to expand market share and brand influence.
On the other hand, regarding the shipment of medical nicotine, the company stated that they are currently in communication with customers. Sample products have been shipped and they are awaiting customer confirmation and the next steps for cooperation.
Regarding the company's business direction for the second quarter, Jincheng Pharm stated that they will continue to focus on production, operations, and market work based on the trends seen in the first quarter. Additionally, the company's nicotine production will mainly be used in the e-liquid for e-cigarettes.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
